The reporter learned from the China Pharmaceutical Industry Development Summit Forum held on the 4th，The National Development and Reform Commission is brewing to adjust the prices of patent medicines，It is expected to be introduced early next year。The target of adjusting the price is the Chinese patent medicine for non -national basic drugs within the government pricing range，The prices of Chinese medicines that enter the national basic drugs will be studied separately。
It is reported，At present, domestic Chinese medicine stake online sports bettingstake online sports bettingproduction enterprises are 2595。& ldquo; Price adjustment plan for rising and lowering, there is a price adjustment plan to encourage low -cost drug production to meet market demand，The biggest impact is an enterprise with a large number of exclusive varieties of Chinese medicine，Sui Ling Pharmaceutical、Tongrentang、Kangyuan Pharmaceutical and other former scenery will no longer，Profit decline becomes an inevitable trend。
& ldquo; In the past few days，The Drug Price Review Center of the Development and Reform Commission organized a meeting of experts in Beijing。Since the start of the price adjustment work at the end of last year，Numerous meetings were held。& rdquo; Sources told the "Economic Reference News" reporter。
It is reported，The Development and Reform Commission has adjusted the four principles of the prices of patent medicines in this adjustment: First, it is necessary to keep the consistency with the price policy of chemical drugs，It is necessary to fully reflect the characteristics of Chinese medicine。Second, fully consider the trend of the price increase of Chinese medicinal materials、The production cost of the leading enterprise of Chinese patent medicine、Market transaction price and other factors。Third, the price does not reduce the price for low -priced drugs，Properly increases prices for inverted prices due to rising costs; appropriately decreases for innovative drugs; increased price Stake Sports Bettingstake online sports bettingreduction for high -priced drugs。Fourth, except for the variety of price increases，The highest retail price after adjustment is not higher than the actual average winning price of the bid。
& ldquo; The price adjustment range argues the most at repeated meetings。& rdquo; Sources revealed to the "Economic Reference News" reporter，In the first round of soliciting comments draft，National Secret Class and above Chinese medicine confidential prescription drugs，The National Development and Reform Commission requires that based on the current retail price，Uniformly adjust to 5 points to reduce。But in the second round of soliciting comments drafts, it was modified to & ldquo; these medicines do not reduce prices & rdquo;。This fully reflects the ideas of government departments to protect the confidentiality prescription of Chinese medicine。
According to the above sources，Except for national confidential varieties，High -quality and high -quality proprietary Chinese medicines need to be adjusted at 10%; after adjustment, the decrease of more than 25%，It can be in place for two years & ldquo; This is a drug introduced for the exclusive varieties of Chinese medicine，Because the exclusive variety of stake betting apptraditional Chinese medicine in recent years is protected by exclusive variety policies、No participation in market price competition，The price is higher than other varieties。& rdquo;
The reporter learned，Stake Sports BettingEnterprises with exclusive stake betting apptraditional Chinese medicine are colleagues、Guangzhou Pharmaceutical、Yiling Pharmaceutical、Tzuhili、Kangyuan Pharmaceutical、Wohua Medicine、Kang Enbei, etc.。The above person pointed out，The exclusive variety of traditional Chinese medicines mainly take the medical sales channel，There is a lot of operating space for the low price，This will greatly reduce the profit of these companies。
& ldquo; The adjustment of drug price should be two -way，It can no longer reduce the price for low -cost drugs，Otherwise, it will be like chemical medicine，Disappear from the market。& rdquo; People in the industry pointed out，Many non -independent Chinese medicines have also reduced prices in the past，But this time it is also forced to reduce the price and it is not reasonable。
He told reporters，The price of non -exclusive proprietary Chinese medicine is based on the cost of raw material more than ten years ago、Artificial costs, etc. can be calculated。But now the price of Chinese medicine raw materials rises too fast、Rising labor costs and upgrading of production factory equipment，No pricing rose and re -prices。This is not in line with the law of the market economy。
According to sources，In principle, the Development and Reform Commission agrees to the Chinese patent medicine that increases more raw materials，Allowable to increase the highest retail price based on cost。But these Chinese patent medicines must stake sports betting appbe a clinical necessary or first -aid drug specified stake betting appin the pharmacopoeia; Chinese medicinal materials account for a large proportion of drug costs; the market price has continued to rise in the past five years。
